Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -13.91% is 43% above its 5-year average of -24.34%, near the high end of its 5-year range (-29.78%–-13.91%).
28.70% above its 12-month average of -19.51%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.26%.
RETURN ON ASSETS (ROA)
-13.91%
RETURN ON ASSETS (ROA) AVG TTM
-19.51%
RETURN ON ASSETS (ROA) AVG 3Y
-22.81%
RETURN ON ASSETS (ROA) AVG 5Y
-24.34%
RETURN ON ASSETS (ROA) AVG 10Y
-32.52%
RETURN ON ASSETS (ROA) AVG 15Y
-18.40%
RETURN ON ASSETS (ROA) AVG 20Y
-17.48%
CURRENT VS TTM AVG
+28.70%
CURRENT VS 3Y AVG
+39.02%
CURRENT VS 5Y AVG
+42.84%
CURRENT VS 10Y AVG
+57.22%
CURRENT VS 15Y AVG
+24.40%
CURRENT VS 20Y AVG
+20.43%
SECTOR MEDIAN · HEALTHCARE
-23.55%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
+40.95%
vs the sector median at left
Alphatec Holdings, Inc.
Market Cap
$1.65B
Return on Assets (ROA)
-13.91%
TTM Avg
-19.51%
3Y Avg
-22.81%
5Y Avg
-24.34%
Market Cap
$1.65B
Return on Assets (ROA)
7.08%
TTM Avg
2.00%
3Y Avg
-0.05%
5Y Avg
-1.77%
Market Cap
$1.71B
Return on Assets (ROA)
-10.49%
TTM Avg
-13.41%
3Y Avg
-10.26%
5Y Avg
-6.23%
Market Cap
$1.57B
Return on Assets (ROA)
-4.89%
TTM Avg
-0.43%
3Y Avg
-0.87%
5Y Avg
-1.37%
Market Cap
$1.76B
Return on Assets (ROA)
3.18%
TTM Avg
-8.22%
3Y Avg
-16.26%
5Y Avg
-17.13%
Market Cap
$1.52B
Return on Assets (ROA)
10.96%
TTM Avg
-5.00%
3Y Avg
-12.25%
5Y Avg
-27.07%
Market Cap
$1.52B
Return on Assets (ROA)
-16.72%
TTM Avg
-18.71%
3Y Avg
-15.50%
5Y Avg
-12.14%
Market Cap
$1.78B
Return on Assets (ROA)
-46.66%
TTM Avg
-46.30%
3Y Avg
-40.19%
5Y Avg
-33.55%
Market Cap
$1.78B
Return on Assets (ROA)
-61.53%
TTM Avg
-47.53%
3Y Avg
-47.53%
5Y Avg
-47.53%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.65B | -13.91% | -19.51% | -22.81% | -24.34% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 7.08% | 2.00% | -0.05% | -1.77% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -10.49% | -13.41% | -10.26% | -6.23% |
| Certara, Inc. (CERT)vs › | $1.57B | -4.89% | -0.43% | -0.87% | -1.37% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 3.18% | -8.22% | -16.26% | -17.13% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 10.96% | -5.00% | -12.25% | -27.07% |
| GH Research PLC (GHRS)vs › | $1.52B | -16.72% | -18.71% | -15.50% | -12.14% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -46.66% | -46.30% | -40.19% | -33.55% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -61.53% | -47.53% | -47.53% | -47.53% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
ROA
-13.9%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -18.12% |
| 2024-12-31 | -20.90% |
| 2023-12-31 | -23.18% |
| 2022-12-31 | -29.04% |
| 2021-12-30 | -25.00% |
| 2020-12-31 | -29.78% |
| 2019-12-31 | -32.58% |
| 2018-12-31 | -22.38% |
| 2017-12-31 | -2.71% |
| 2016-12-31 | -32.19% |
| 2015-12-31 | -121.79% |
| 2014-12-31 | -3.73% |
| 2013-12-31 | -22.49% |
| 2012-12-31 | -4.05% |
| 2011-12-31 | -6.05% |
| 2010-12-31 | -3.81% |
| 2009-12-31 | -8.21% |
| 2008-12-31 | -18.83% |
| 2007-12-31 | -13.72% |
| 2006-12-31 | -19.97% |
| 2005-12-31 | -12.88% |
| 2004-12-31 | 4.51% |
| 2003-12-31 | 0.00% |
| 2002-12-31 | -14.72% |
| 2001-12-31 | 1.00% |
